ALLO vs REG · rev $22.0K vs P/E 34, $12.93B cap
Allogene Therapeutics Inc (ALLO) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
REG does not have a complete income-statement cache yet.
ALLO currently screens at market cap $258.1M. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the ALLO and REG stock pages for the full models.
Not investment advice.